Speech Accessibility Project starts recruitment of U.S. and Puerto Rican stroke survivors

The Speech Accessibility Project has begun recruiting U.S. and Puerto Rican adults who have had a stroke.

AstraZeneca, Gilead detail TROP2 ADC data in lung cancer as they search for new ways forward

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 10, 2024

CMS Finalizes New Interoperability and Prior Authorization Rule

What You Should Know: The Biden-Harris Administration has finalized a new rule that streamlines the prior authorization process and improves health data exchange across the

January 18, 2024

Novartis’ urticaria drug meets all endpoints in Phase III trials – Pharmaceutical Technology

Remibrutinib is forecasted to generate $237m in 2034 in US sales, as per GlobalData’s Expiry model. Image Credit: Michael Derrer Fuchs / Shutterstock. Novartis’ remibrutinib

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.